Contract facts
NONENo full NAICS 811219 intel page yet. Browse NAICS intelligence
BIOFIRE FIL ARRAY EXTENDED WARRANTY MAINTENANCE AND REPAIR FOR INFECTION DISEASE ANALYZERS. REMOVING CLIN 0001, 1001, 2001, 3001 AND 4001 FROM THE CONTRACT. EXERCISE OP YR 2 is a federal NONE award for 249-Network Contract Office 9 (36C249) held by Biofire Diagnostics, LLC. Estimated value $375K ($291K obligated). Current period of performance ends Feb 28, 2027. Last award drew 1 bidder. Place of performance: NASHVILLE TN. Related solicitation 36C24922Q0151.
BIOFIRE FIL ARRAY EXTENDED WARRANTY MAINTENANCE AND REPAIR FOR INFECTION DISEASE ANALYZERS. REMOVING CLIN 0001, 1001, 2001, 3001 AND 4001 FROM THE CONTRACT. EXERCISE OP YR 2
Recompete timing
PublicCurrent PoP ends Feb 28, 2027 (191 days remaining). Agencies typically plan 12–18 months ahead — at 6.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordBiofire Diagnostics, LLC — $14.7M obligated across 200 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24922P0326?
36C24922P0326 (Biofire FIL ARRAY extended warranty maintenance) is a 249-Network Contract Office 9 (36C249) award with a potential value of $375K, currently held by Biofire Diagnostics, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C249-22-P-0326?
36C249-22-P-0326 is the dashed form of PIID 36C24922P0326 (Biofire FIL ARRAY extended warranty maintenance), held by Biofire Diagnostics, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24922P0326?
249-Network Contract Office 9 (36C249) awarded 36C24922P0326 to Biofire Diagnostics, LLC (potential $375K).
Who is the incumbent on 36C24922P0326?
Biofire Diagnostics, LLC is the incumbent with $14.7M across 200 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2027.
When does Biofire Diagnostics, LLC’s 36C24922P0326 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
